AGP Executive Report
Last update: 11 hours agoCancer AI: Mass General Brigham researchers developed AI tools that estimate biological age and predict cancer survival from a face photo. The early findings need more validation before the tools could guide care. Biotech: Boston-based Rapport Therapeutics reported positive Phase 2 results for RAP-219 in adults with bipolar mania; the trial met its main and secondary measures, with no severe treatment-related events reported. Cancer Care: Dana-Farber and Beth Israel Deaconess broke ground on a $1.68 billion, 300-bed cancer hospital in Boston, designed to bring research and inpatient care together. Fusion Startups: Cambridge Heavy Industries raised $6.2 million to develop a benchtop laser-fusion device.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.